These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31081900)

  • 21. Dynamin and PTP-PEST cooperatively regulate Pyk2 dephosphorylation in osteoclasts.
    Eleniste PP; Du L; Shivanna M; Bruzzaniti A
    Int J Biochem Cell Biol; 2012 May; 44(5):790-800. PubMed ID: 22342188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic mechanisms of glucocorticoid-induced osteoporosis.
    Chen M; Fu W; Xu H; Liu CJ
    Cytokine Growth Factor Rev; 2023 Apr; 70():54-66. PubMed ID: 36906448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis.
    Buckbinder L; Crawford DT; Qi H; Ke HZ; Olson LM; Long KR; Bonnette PC; Baumann AP; Hambor JE; Grasser WA; Pan LC; Owen TA; Luzzio MJ; Hulford CA; Gebhard DF; Paralkar VM; Simmons HA; Kath JC; Roberts WG; Smock SL; Guzman-Perez A; Brown TA; Li M
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10619-24. PubMed ID: 17537919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pyk2 inhibitor incorporated into a PEGDA-gelatin hydrogel promotes osteoblast activity and mineral deposition.
    Posritong S; Flores Chavez R; Chu TG; Bruzzaniti A
    Biomed Mater; 2019 Feb; 14(2):025015. PubMed ID: 30658347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoids and the osteoclast.
    Kim HJ; Zhao H; Kitaura H; Bhattacharyya S; Brewer JA; Muglia LJ; Patrick Ross F; Teitelbaum SL
    Ann N Y Acad Sci; 2007 Nov; 1116():335-9. PubMed ID: 18083935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
    Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.
    Lee EJ; Kim JL; Gong JH; Park SH; Kang YH
    Biomed Res Int; 2015; 2015():680145. PubMed ID: 25834823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.
    Katsume A; Okigaki M; Matsui A; Che J; Adachi Y; Kishita E; Yamaguchi S; Ikeda K; Ueyama T; Matoba S; Yamada H; Matsubara H
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1084-92. PubMed ID: 21372295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo.
    Chiusaroli R; Knobler H; Luxenburg C; Sanjay A; Granot-Attas S; Tiran Z; Miyazaki T; Harmelin A; Baron R; Elson A
    Mol Biol Cell; 2004 Jan; 15(1):234-44. PubMed ID: 14528021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A; Rogers MJ; Idris AI; Crockett JC
    Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts.
    Zhang Z; Neff L; Bothwell AL; Baron R; Horne WC
    Bone; 2002 Sep; 31(3):359-65. PubMed ID: 12231407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum CTX levels and histomorphometric analysis in Src versus RANKL knockout mice.
    Takeshita S; Fumoto T; Ito M; Ikeda K
    J Bone Miner Metab; 2018 May; 36(3):264-273. PubMed ID: 28589412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAK2-IGF1 axis in osteoclasts regulates postnatal growth in mice.
    Dodington DW; Yumol JL; Yang J; Pollock-Tahiri E; Sivasubramaniyam T; Sacco SM; Schroer SA; Li YE; Le H; Ward WE; Woo M
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33682794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.
    Rucci N; Capulli M; Ventura L; Angelucci A; Peruzzi B; Tillgren V; Muraca M; Heinegård D; Teti A
    J Bone Miner Res; 2013 Sep; 28(9):1912-24. PubMed ID: 23559035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
    Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.